Report Categories
View AllRecent Articles
View All
Synthetic GJT Stock Today Unchanged at 2295 Key Levels 20260520
Eltek ELTK Q1 2026 Earnings No Surprises But Whats Next
RMTI Q1 2026 Earnings EPS Misses Estimates as Stock Declines
Axogen Q1 2026 Earnings EPS Misses Estimates Shares Slide on Slight Miss
RKDA Q3 2025 Earnings Massive EPS Surprise Driven by NonOperating Gains Revenue Still Absent
Omada Health Inc OMDA Q1 2026 Earnings Narrowerthanexpected Loss Boosts Investor Sentiment
MED Q1 2026 Earnings EPS Surprises with Smaller Loss Than Expected
RCMT Q1 2026 Earnings EPS Misses Estimates Stock Declines
Silence Therapeutics SLN Retreats Support Levels in Focus After Modest Decline
CarMax KMX Earnings History Suggests Potential for Another Beat in Upcoming Report
STRO Q1 2026 Earnings Narrower than Expected Loss but Stock Declines
Zepto Unlisted Shares Tumble 30 Despite Securing SEBI Approval for IPO
External Links
FULTP Q1 2026 Earnings EPS Beats Estimates Preferred Stock Declines Slightly
Eton Pharmaceuticals ETON Slumps Key Support Levels Tested After Sharp Decline
Nektar Therapeutics NKTR Holds Steady Near Support Amid Low Volatility
Guardforce AI GFAI Hovers Near Support Amid Modest Decline
Compugen CGEN Drops Nearly 4 as Stock Tests Key Support Levels
Erasca Inc ERAS Surges 365 as Biotech Sentiment Lifts Stock Above Key Support
Oruka Therapeutics ORKA Edges Higher Testing Key Resistance at 6146
Sypris Solutions SYPR Slides 5 as Selling Pressure Tests Key Support Zone